<DOC>
	<DOCNO>NCT00689598</DOCNO>
	<brief_summary>To determine whether spironolactone prevent delay occurrence atrial fibrillation .</brief_summary>
	<brief_title>Spironolactone Paroxysmal Atrial Fibrillation</brief_title>
	<detailed_description>To determine whether add spironolactone prevent delay occurrence paroxysmal atrial fibrillation patient receive propafenone treatment .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<criteria>Inclusion criterion : 1 . 18 80 Y/O , 2 . Paroxysmal AF . Exclusion criterion : 1 . GPT &gt; 100 IU/L tota bilirubin &gt; 2 mg/dl ; 2 . Creatinine &gt; 2 mg/dl ; 3 . Serum potassium &gt; = 5 mM ; 4 . Serum sodium &lt; =130 mM ; 5 . Uric acid &gt; 10 mg/dlã€‚</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Atrial fibrillation , spironolactone</keyword>
</DOC>